Asthma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older who have been diagnosed with asthma by a doctor, and whose doctor has prescribed them Enerzair inhalation capsules (a combination inhaler containing indacaterol acetate, glycopyrronium bromide, and mometasone furoate) used with a Breezhaler device, in line with the approved prescribing information
- People who have been given a clear explanation of the study by the trial team and have signed a consent form agreeing to how their data will be collected and used
Who may not be able to join:
- People who have a known allergic or sensitivity reaction to Enerzair or any of its ingredients
- People who have hereditary conditions affecting how the body processes certain sugars (such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption), as Enerzair contains lactose
- People who are currently experiencing sudden or severe asthma symptoms, including episodes of airway tightening that require a fast-acting reliever inhaler
- People who are already taking part in another clinical trial that involves a treatment or intervention
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Novartis Pharmaceuticals, Novartis Pharmaceuticals
Phone: +41613241111
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of adverse events and serious adverse events; Incidence of unexpected adverse events and unexpected serious adverse events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.